Artery blockage symptoms
Pro Research Analysisby 
Searched over 200M research papers
Symptoms of Artery Blockage: Understanding Peripheral and Coronary Artery Disease
Peripheral Artery Disease (PAD) Symptoms
Intermittent Claudication and Pain
Peripheral artery disease (PAD) primarily affects the arteries supplying blood to the lower limbs, often due to atherosclerosis. One of the hallmark symptoms of PAD is intermittent claudication, which is characterized by pain, numbness, weakness, or fatigue in the muscles of the lower extremities during exercise, which typically resolves with rest 135. This pain usually occurs in the calf but can also affect the buttocks, thighs, or legs depending on the location of the arterial blockage 4.
Critical Limb Ischemia (CLI)
In severe cases, PAD can progress to critical limb ischemia (CLI), a condition marked by severe pain at rest, non-healing wounds, and a high risk of limb loss and mortality due to cardiovascular events 1. CLI is a serious manifestation that often requires surgical or endovascular revascularization to restore blood flow 1.
Reduced Walking Ability and Exercise Performance
Patients with PAD often experience a significant reduction in their ability to walk and perform daily activities. This is due to the impaired supply of oxygen and nutrients to the muscles during exercise, leading to early fatigue and pain 36. The severity of these symptoms can vary widely among patients, with some experiencing mild discomfort and others facing debilitating pain 5.
Coronary Artery Disease (CAD) Symptoms
Chest Pain and Heart Attack
Coronary artery disease (CAD) occurs when the coronary arteries, which supply blood to the heart, become blocked due to plaque buildup. This condition can lead to chest pain (angina) and, in severe cases, heart attacks 2. The symptoms of CAD often become apparent only when the disease has progressed significantly, making early detection challenging 2.
Reduced Left Ventricular Ejection Fraction
An increase in coronary arterial resistance due to blockage can reduce the left ventricular ejection fraction, which is a measure of the heart's pumping efficiency. This reduction in ejection fraction can serve as an indicator of coronary artery blockage and is associated with a deterioration in the heart's systolic function 2.
Conclusion
Artery blockage, whether in the peripheral or coronary arteries, presents with distinct symptoms that can significantly impact a patient's quality of life. In PAD, symptoms range from intermittent claudication to critical limb ischemia, while CAD primarily manifests as chest pain and can lead to heart attacks. Early detection and appropriate management are crucial in mitigating the severe consequences of these conditions. Understanding the symptoms and underlying mechanisms can aid in the development of targeted therapeutic strategies to improve patient outcomes.
Sources and full results
Most relevant research papers on this topic
A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease
Circulating biomarkers show promise in predicting peripheral artery disease progression and response to therapies, but larger studies are needed to confirm their clinical value over existing risk predictors.
Literature Review
Highly CitedModeling of cardiovascular circulation for the early detection of coronary arterial blockage.
The study developed a cardiovascular modeling technique that can effectively detect early coronary arterial blockage by estimating coronary arterial resistance from blood pressure measurements.
Pathophysiology of Intermittent Claudication in Peripheral Artery Disease.
Intermittent claudication in peripheral artery disease is driven by inflammation, vascular dysfunction, reduced microvascular flow, impaired angiogenesis, and altered skeletal muscle function.
Highly CitedDiagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.
Chronic arterial insufficiency of the lower extremities is often diagnosed and treated as a sign of systemic atherosclerosis, with relatively benign prognosis for the affected limb and relatively low need for amputation.
Literature ReviewHighly CitedManagement of peripheral arterial disease and intermittent claudication.
Exercise and risk factor modification are key to managing peripheral arterial disease and intermittent claudication, while preventing disease progression.
Systematic ReviewHighly CitedPathogenesis of the limb manifestations and exercise limitations in peripheral artery disease.
Peripheral artery disease reduces exercise performance due to multiple pathophysiologic mechanisms, including atherosclerotic obstructions, oxidative stress, inflammation, and muscle metabolic abnormalities.
Literature Review
Rigorous JournalHighly CitedMachine Learning Confirms Nonlinear Relationship between Severity of Peripheral Arterial Disease, Functional Limitation and Symptom Severity
Machine learning reveals a nonlinear relationship between peripheral arterial disease severity, functional limitation, and symptom severity, with some patients experiencing asymptomatic symptoms.
Observational StudyRigorous JournalProniosomes Nanoparticle for the Treatment of Peripheral Arterial Disease.
Proniosome nanoparticles show good characteristics and effectiveness for treating peripheral arterial diseases, increasing drug stability and entrapment while delivering them without special handling or storage conditions.
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Cilostozol and naftidrofuryl oxalate significantly improve walking distance in patients with peripheral arterial disease, while inositol nicotinate shows potential in improving health-related quality of life.
Highly Cited